Company profile
MNS | Revolutionising Medicine Delivery | MNS
Transforming global healthcare with self-administered microneedle vaccine patches. Safe, efficient, and accessible- bringing vaccinations to homes worldwide.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jan 2026 to 31 Dec 2026
Microneedle Solutions (MNS), a Leeds-based microneedle manufacturing start-up, is pioneering a transformative approach to drug delivery through its proprietary microneedle patch platform. This project will advance the development of our novel vaccine patch technology by initiating a First-in-Human (FIH) Phase 1 clinical trial in collaboration with Leeds T...
1 Aug 2024 to 31 Jan 2025
MNS is at the forefront of revolutionising vaccine delivery through our groundbreaking mRNA vaccine patch immunogenicity project. Our endeavour focuses on developing innovative vaccine patches, as a pioneering needle free approach set to transform traditional vaccine administration methods. Our project is driven by the need for more efficient and accessib...
